ACE-031 (1mg) Research Compound | Elite Peptide

ACE-031 Peptide (ActRIIB-IgG1) – Research Compound

Overview

ACE-031 peptide, also called ActRIIB-IgG1, is a recombinant research compound designed as a myostatin inhibitor. It fuses the activin receptor type IIB (ACV2RB) with the IgG1-Fc antibody fragment. Because of this structure, it may block circulating myostatin and reduce its limiting effect on muscle growth.

Myostatin, also known as growth and differentiation factor 8 (GDF8), regulates skeletal muscle development. When ACE-031 prevents myostatin from binding to ACV2RB receptors, pathways that support muscle hypertrophy, fat metabolism, and bone density can activate normally. As a result, researchers often explore this compound in studies focused on muscle growth and performance.

Chemical Makeup

• Molecular Formula: C3418H5188N928O1062S38

• Molecular Weight: 77,489.82 g/mol

• Other Known Titles: ActRIIB-IgG1, Soluble Activin Type IIB Receptor

Research and Clinical Studies

Muscle Growth and Hypertrophy
A double-blind, placebo-controlled study showed that ACE-031 exposure increased muscle mass. Within 29 days, researchers measured a 3.3% rise in total body lean mass and a 5.1% increase in quadriceps femoris muscle volume.

Fat Metabolism
Transitioning to metabolic studies, scientists observed that inhibiting myostatin reduced fat buildup and promoted fatty acid oxidation. In obesity-related murine models, ACE-031 use correlated with improved energy metabolism and less fat accumulation.

Muscle Performance
Additional experimental data revealed that ACE-031 improved contractile force and energy expenditure in muscle tissue. Murine models demonstrated a 33% gain in muscle volume along with better oxygen consumption, highlighting its potential role in muscle efficiency.

Bone Density
In Duchenne Muscular Dystrophy (DMD) models, ACE-031 also supported bone health. Studies reported up to an 80% increase in femoral bone volume and a 70% improvement in trabecular number. Consequently, researchers link this peptide with stronger bone mineralization.

Important Notice

ACE-031 peptide is intended strictly for research and laboratory purposes. It is not approved for human, medical, or veterinary use.